BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19487854)

  • 1. PET/CT staging and response evaluation of post-transplantation lymphoproliferative disease (PTLD).
    Chowdhury FU; Sheerin F; Bradley KM; Gleeson FV
    Clin Nucl Med; 2009 Jun; 34(6):386-7. PubMed ID: 19487854
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical usefulness of FDG-PET/CT scan imaging in the management of posttransplant lymphoproliferative disease.
    Bianchi E; Pascual M; Nicod M; Delaloye AB; Duchosal MA
    Transplantation; 2008 Mar; 85(5):707-12. PubMed ID: 18337664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttransplant lymphoproliferative disease in a pediatric patient as seen on PET/CT scan.
    Bagga S
    Clin Nucl Med; 2007 Jul; 32(7):553-4. PubMed ID: 17581345
    [No Abstract]   [Full Text] [Related]  

  • 4. FDG PET imaging in the evaluation of post-transplant lymphoproliferative disorder following renal transplantation.
    O'Conner AR; Franc BL
    Nucl Med Commun; 2005 Dec; 26(12):1107-11. PubMed ID: 16264358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of F-18 FDG PET/CT in the evaluation of neck swelling in polymorphic posttransplant lymphoproliferative disorder after renal transplantation.
    Kim SH; Zeon SK; Choi BW; Kim HW; Won KS; Kim SJ
    Clin Nucl Med; 2011 Jul; 36(7):587-9. PubMed ID: 21637068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both native and ectopically transplanted hearts shown on FDG PET/CT in a PTLD patient.
    Sonoda LI; Sanghera B; Gogbashian A; Lambert J; Wong WL
    Clin Nucl Med; 2012 Oct; 37(10):1022-3. PubMed ID: 22899204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography scanning in the setting of post-transplant lymphoproliferative disorders.
    Blaes AH; Cioc AM; Froelich JW; Peterson BA; Dunitz JM
    Clin Transplant; 2009; 23(6):794-9. PubMed ID: 20447185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG PET/CT Findings of the Recurrent Posttransplantation Lymphoproliferative Disorder in a Pediatric Liver Transplant Recipient With Right Leg Pain as the Only Complaint.
    Bai X; Yang H; Zhuang H
    Clin Nucl Med; 2015 Oct; 40(10):832-4. PubMed ID: 26098286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG PET/CT Findings of Polymorphic Posttransplant Lymphoproliferative Disorders in a Transplanted Kidney.
    Yang Y; Wang W; Kan Y; Liu J; Yang J
    Clin Nucl Med; 2018 Jun; 43(6):441-444. PubMed ID: 29485445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post transplant lymphoproliferative disease in pediatric solid organ transplant patients: a possible role for [18F]-FDG-PET(/CT) in initial staging and therapy monitoring.
    von Falck C; Maecker B; Schirg E; Boerner AR; Knapp WH; Klein C; Galanski M
    Eur J Radiol; 2007 Sep; 63(3):427-35. PubMed ID: 17293073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG-PET/CT in abdominal post-transplant lymphoproliferative disease.
    Metser U; Lo G
    Br J Radiol; 2016; 89(1057):20150844. PubMed ID: 26544161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography in the diagnosis and therapeutic monitoring of post-transplant lymphoproliferative disorder after cord blood transplantation.
    Kataoka K; Seo S; Ota S; Takahashi T; Kurokawa M
    Bone Marrow Transplant; 2010 Mar; 45(3):610-2. PubMed ID: 19684636
    [No Abstract]   [Full Text] [Related]  

  • 13. Hodgkin lymphoma post-transplant lymphoproliferative disorder following pediatric renal transplant: serial imaging with F-18 FDG PET/CT.
    Makis W; Lisbona R; Derbekyan V
    Clin Nucl Med; 2010 Sep; 35(9):704-5. PubMed ID: 20706047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-FDG PET for Detection of Primary Tracheobronchial T-/Natural Killer-Cell-Derived Posttransplant Lymphoproliferative Disorder After Lung Transplantation.
    Derlin T; Braubach P; Kreipe HH; Hueper K
    Clin Nucl Med; 2017 Dec; 42(12):988-989. PubMed ID: 29076909
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Song H; Guja KE; Iagaru A
    Semin Nucl Med; 2021 Jul; 51(4):392-403. PubMed ID: 33455722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttransplant Lymphoproliferative Disorder of the Thorax: CT and FDG-PET Features in a Single Tertiary Referral Center.
    Yoon GY; Kim MY; Huh JR; Jo KW; Shim TS
    Medicine (Baltimore); 2015 Aug; 94(31):e1274. PubMed ID: 26252295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CT findings in posttransplantation lymphoproliferative disorder of renal transplants.
    Vrachliotis TG; Vaswani KK; Davies EA; Elkahammas EA; Bennett WF; Bova JG
    AJR Am J Roentgenol; 2000 Jul; 175(1):183-8. PubMed ID: 10882272
    [No Abstract]   [Full Text] [Related]  

  • 18. FDG PET/CT in a patient with spontaneous remission of methotrexate-associated lymphoproliferative disorders after interruption of methotrexate.
    Kuramoto R; Hirata K; Takei T; Oridate N; Suzuki S; Yamada Y; Imamura M; Tamaki N
    Clin Nucl Med; 2011 Jul; 36(7):582-3. PubMed ID: 21637066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTLD visualization by FDG-PET: improved detection of extranodal localizations.
    Bakker NA; Pruim J; de Graaf W; van Son WJ; van der Jagt EJ; van Imhoff GW
    Am J Transplant; 2006 Aug; 6(8):1984-5. PubMed ID: 16889556
    [No Abstract]   [Full Text] [Related]  

  • 20. Performance of advanced imaging modalities at diagnosis and treatment response evaluation of patients with post-transplant lymphoproliferative disorder: A systematic review and meta-analysis.
    Montes de Jesus FM; Kwee TC; Nijland M; Kahle XU; Huls G; Dierckx RAJO; van Meerten T; Gheysens O; Dierickx D; Vergote V; Noordzij W; Glaudemans AWJM
    Crit Rev Oncol Hematol; 2018 Dec; 132():27-38. PubMed ID: 30447925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.